BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 29667084)

  • 1. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
    Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
    J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
    Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
    Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma.
    Talari NK; Panigrahi MK; Madigubba S; Phanithi PB
    J Neurooncol; 2018 Apr; 137(2):241-248. PubMed ID: 29302888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
    Cheong JE; Sun L
    Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kynurenine pathway in brain tumor pathogenesis.
    Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ
    Cancer Res; 2012 Nov; 72(22):5649-57. PubMed ID: 23144293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
    Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
    Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.
    Opitz CA; Litzenburger UM; Sahm F; Ott M; Tritschler I; Trump S; Schumacher T; Jestaedt L; Schrenk D; Weller M; Jugold M; Guillemin GJ; Miller CL; Lutz C; Radlwimmer B; Lehmann I; von Deimling A; Wick W; Platten M
    Nature; 2011 Oct; 478(7368):197-203. PubMed ID: 21976023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine produced by tryptophan 2,3-dioxygenase metabolism promotes glioma progression through an aryl hydrocarbon receptor-dependent signaling pathway.
    Ma W; Ye L; Zhong C; Li J; Ye F; Lv L; Yu Y; Jiang S; Zhou P
    Cell Biol Int; 2022 Oct; 46(10):1577-1587. PubMed ID: 35702760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
    Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
    Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
    Labadie BW; Bao R; Luke JJ
    Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression.
    Matheus LHG; Dalmazzo SV; Brito RBO; Pereira LA; de Almeida RJ; Camacho CP; Dellê H
    BMC Cancer; 2020 Sep; 20(1):869. PubMed ID: 32907554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma.
    Guastella AR; Michelhaugh SK; Klinger NV; Kupsky WJ; Polin LA; Muzik O; Juhász C; Mittal S
    Mol Imaging; 2016; 15():. PubMed ID: 27151136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner.
    Li F; Zhao Z; Zhang Z; Zhang Y; Guan W
    BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
    Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
    Front Immunol; 2020; 11():55. PubMed ID: 32117235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1.
    Zitron IM; Kamson DO; Kiousis S; Juhász C; Mittal S
    Cancer Biol Ther; 2013 Apr; 14(4):333-9. PubMed ID: 23358471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stemness and immune evasion conferred by the TDO2-AHR pathway are associated with liver metastasis of colon cancer.
    Miyazaki T; Chung S; Sakai H; Ohata H; Obata Y; Shiokawa D; Mizoguchi Y; Kubo T; Ichikawa H; Taniguchi H; Aoki K; Soga T; Nakagama H; Okamoto K
    Cancer Sci; 2022 Jan; 113(1):170-181. PubMed ID: 34714577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition.
    Dos Santos IL; Mitchell M; Nogueira PAS; Lafita-Navarro MC; Perez-Castro L; Eriom J; Kilgore JA; Williams NS; Guo L; Xu L; Conacci-Sorrell M
    FEBS J; 2024 May; 291(10):2172-2190. PubMed ID: 38431776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
    Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
    D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
    Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.